Research findings, pricing news, and vendor analysis across the peptide market.
Showing 1 to 30 of 31
Retatrutide vial size and BAC water volume determine concentration and U-100 syringe units, not the total peptide in the vial. Use worked 10 mg to 50 mg examples, then compare current price per verified milligram and lot-level testing before buying.
Read more →Retatrutide exercise questions are surging, but the trials did not test workout performance directly. Compare the fatigue and body-composition data, protect training quality, and check price per verified milligram before buying.
Read more →A useful peptide vial label records the compound, lot, tested fill, diluent volume, concentration, and dates in one place. Learn how COA-adjusted math changes concentration, then use PeptidePub to compare the vial, vendor proof, supplies, and delivered value before buying.
Read more →Retatrutide results can look slow or inconsistent because trial averages hide individual variation, short-term scale noise, concentration errors, and product-quality problems. Use this checklist to separate timing, fatigue, measurement, and vial-proof questions before comparing a replacement lot or vendor.
Read more →Cagrilintide buyers can use human trial ranges to understand the evidence, then compare 10 mg vial math, current price per mg, discount codes, and lot-specific COA proof before buying.
Read more →PT-141 buyers need to separate the studied 1.75 mg bremelanotide reference dose from research-vial concentration math. This guide covers timing, 10 mg reconstitution examples, current cost per 1.75 mg equivalent, and the COA checks to make before buying.
Read more →AOD-9604 buyers need to separate commonly reported subcutaneous protocols from the oral and intravenous doses actually studied in humans. This guide provides 5 mg vial math, current price-per-mg comparisons, trial data, and the COA checks to use before buying.
Read more →GHK-Cu injection-site burning can reflect concentration, product quality, diluent, handling, or technique, and the symptom alone cannot identify the cause. This guide shows the concentration math, red flags, COA checks, and current price-per-mg comparisons buyers should review before choosing a vial.
Read more →TB-500 buyers need three numbers before comparing a vial: exact product identity, concentration after reconstitution, and delivered cost per verified milligram. This guide explains reported protocol ranges, 5 mg and 10 mg vial math, current prices, and the COA checks that separate a strong buy from a cheap label.
Read more →A 10 mg vial can produce very different concentrations depending on the amount of bacteriostatic water added. This chart converts 1 to 5 mL dilution choices into mg/mL, mcg per U-100 syringe unit, and example draw-unit math, then routes buyers to current prices and verified vendors.
Read more →No controlled human study shows that BPC-157 causes cancer, but its effects on blood-vessel signaling make the question worth answering precisely. Here is what the angiogenesis research shows, what it does not prove, and how buyers can compare BPC-157 by price and testing proof.
Read more →Understand the BPC-157 ranges most often reported online, how 5 mg and 10 mg vial math works, and what each measured amount costs across current vendors. Compare price, COA proof, and vial size before buying.
Read more →Retatrutide combines GLP-1, GIP, and glucagon receptor activity in one molecule. Learn what each target contributes and what Phase 2 and Phase 3 evidence can actually establish.
Read more →New to peptides? Use this first-vial checklist to choose the right compound, compare price per mg, verify the COA, understand vial math, and buy from a vendor with proof.
Read more →MOTS-c buyers commonly ask where a subcutaneous injection goes, why site rotation matters, and how vial concentration changes the volume being handled. This practical guide connects general injection-site guidance with reconstitution math, current MOTS-c prices, and the COA checks to run before buying.
Read more →Opened multi-dose bacteriostatic water is generally dated and discarded within 28 days unless its manufacturer specifies another period. Learn what the rule actually means, when to discard sooner, and why a smaller vial can deliver better usable value.
Read more →Protect the value in every vial with a practical storage plan for dry and reconstituted peptides. Compare refrigeration, freezing, light, moisture, temperature swings, and vendor labeling before buying or opening a vial.
Read more →Reconstitution gets easier when buyers separate vial strength, BAC water volume, concentration, and U-100 syringe units. This guide explains the math, compares current BAC water prices, and shows what to verify before adding supplies and peptides to the same cart.
Read more →Wegovy injection is FDA-labeled for adolescents 12 and older with obesity, but pediatric GLP-1 care is not adult weight-loss care copied onto children. Parents should understand the age boundary, trial data, side-effect signals, growth and nutrition monitoring, and why compounded or gray-market pediatric GLP-1 use is a hard no.
Read more →Retatrutide produces the largest weight loss of any drug in this class, but with a heavier, dose-dependent side effect load. Here is what the Phase 3 TRIUMPH-4 data shows on nausea, dysesthesia, discontinuation rates, and the safety questions that remain before FDA approval.
Read more →Most weight-loss peptide stacks sold online have zero combination evidence. This guide ranks popular combinations from RCT-backed co-formulations to community protocols with no human data.
Read more →A beginner-friendly guide to GLP-1 weight-loss peptides. Learn what semaglutide, tirzepatide, and retatrutide do, realistic results, side effects, costs, safety red flags, and how to start safely.
Read more →The best oral GLP-1 depends on whether you care most about weight-loss evidence, simple dosing, diabetes coverage, or cash-pay access. This guide ranks Wegovy pill, Foundayo, Rybelsus, and compounded oral paths.
Read more →GLP-1 drugs can slow stomach emptying, which may change how some oral medicines are absorbed. The clearest contraception warning is for tirzepatide: use non-oral contraception or add a barrier method for 4 weeks after starting and after each dose increase.
Read more →Oral semaglutide is now a real weight-loss option, but the pill has strict absorption rules, pricing caveats, and evidence limits. This guide explains Wegovy pill vs Rybelsus, OASIS 4 data, dosing friction, cost, side effects, and how it compares with injectable Wegovy and orforglipron.
Read more →GLP-1 medications mostly reduce fat mass, but clinical body-composition substudies show some lean mass loss is real. The practical answer is not panic, it is protein, resistance training, slower loss when appropriate, and tracking strength, not just scale weight.
Read more →Most people notice appetite changes within 1-2 weeks, but meaningful weight loss takes 8-12 weeks. Here's the realistic week-by-week timeline from clinical trials.
Read more →Same active ingredient, 80% cheaper. So what's the catch? An honest look at the differences between FDA-approved Ozempic and compounded semaglutide — and how to decide.
Read more →Starting Ozempic, Wegovy, or Mounjaro and wondering about drinking? Research shows GLP-1s significantly reduce alcohol cravings — but also change your tolerance in ways that matter practically.
Read more →Most people regain two-thirds of their lost weight within a year of stopping GLP-1 medications. Here's what the clinical trials show, why it happens biologically, and practical strategies to minimize regain.
Read more →STOP PIECING IT TOGETHER
We wrote the shortcut: five books, 45 compounds, every claim graded by the strength of the real evidence. No hype, no gatekeeping, and free updates for life whenever the market shifts. Most readers say it replaces months of forum digging.
